DK1399143T3 - Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni - Google Patents
Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoniInfo
- Publication number
- DK1399143T3 DK1399143T3 DK02741156T DK02741156T DK1399143T3 DK 1399143 T3 DK1399143 T3 DK 1399143T3 DK 02741156 T DK02741156 T DK 02741156T DK 02741156 T DK02741156 T DK 02741156T DK 1399143 T3 DK1399143 T3 DK 1399143T3
- Authority
- DK
- Denmark
- Prior art keywords
- anhedonia
- carnitine
- medicament
- treatment
- acetyl
- Prior art date
Links
- 208000007415 Anhedonia Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- -1 alkanoyl L-carnitine Chemical compound 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001RM000292A ITRM20010292A1 (it) | 2001-05-29 | 2001-05-29 | Uso dell'acetil l-carnitina per la preparazione di un medicamento peril trattamento dell'anedonia. |
| IT2001RM000319A ITRM20010319A1 (it) | 2001-06-08 | 2001-06-08 | Uso di una alcanoil l-carnitina per la preparazione di un medicamentoper il trattamento dell'anedonia. |
| PCT/IT2002/000339 WO2002096411A1 (en) | 2001-05-29 | 2002-05-24 | Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1399143T3 true DK1399143T3 (da) | 2007-03-26 |
Family
ID=26332845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02741156T DK1399143T3 (da) | 2001-05-29 | 2002-05-24 | Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20040171685A1 (da) |
| EP (1) | EP1399143B1 (da) |
| JP (1) | JP2004532867A (da) |
| KR (1) | KR20040003031A (da) |
| AT (1) | ATE345124T1 (da) |
| CA (1) | CA2448246A1 (da) |
| CZ (1) | CZ20033222A3 (da) |
| DE (1) | DE60216090T2 (da) |
| DK (1) | DK1399143T3 (da) |
| ES (1) | ES2275881T3 (da) |
| HU (1) | HUP0400007A2 (da) |
| MX (1) | MXPA03010920A (da) |
| PL (1) | PL367628A1 (da) |
| PT (1) | PT1399143E (da) |
| SK (1) | SK15862003A3 (da) |
| WO (1) | WO2002096411A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20020620A1 (it) * | 2002-12-13 | 2004-06-14 | Sigma Tau Ind Farmaceuti | Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa. |
| US12226385B2 (en) | 2021-11-12 | 2025-02-18 | Celagenex Research (India) Private Ltd. | Synergistic composition for activating intracellular secondary messenger(cAMP) pathway |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4346107A (en) * | 1979-02-12 | 1982-08-24 | Claudio Cavazza | Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism |
| IT1291930B1 (it) * | 1997-06-18 | 1999-01-21 | Sigma Tau Ind Farmaceuti | Composizione riequilibratrice delle turbe dell'umore in individui sani |
-
2002
- 2002-05-24 CA CA002448246A patent/CA2448246A1/en not_active Abandoned
- 2002-05-24 US US10/478,998 patent/US20040171685A1/en not_active Abandoned
- 2002-05-24 MX MXPA03010920A patent/MXPA03010920A/es active IP Right Grant
- 2002-05-24 WO PCT/IT2002/000339 patent/WO2002096411A1/en not_active Application Discontinuation
- 2002-05-24 JP JP2002592921A patent/JP2004532867A/ja active Pending
- 2002-05-24 PL PL02367628A patent/PL367628A1/xx unknown
- 2002-05-24 CZ CZ20033222A patent/CZ20033222A3/cs unknown
- 2002-05-24 DE DE60216090T patent/DE60216090T2/de not_active Expired - Fee Related
- 2002-05-24 KR KR10-2003-7015576A patent/KR20040003031A/ko not_active Application Discontinuation
- 2002-05-24 ES ES02741156T patent/ES2275881T3/es not_active Expired - Lifetime
- 2002-05-24 HU HU0400007A patent/HUP0400007A2/hu unknown
- 2002-05-24 PT PT02741156T patent/PT1399143E/pt unknown
- 2002-05-24 EP EP02741156A patent/EP1399143B1/en not_active Expired - Lifetime
- 2002-05-24 DK DK02741156T patent/DK1399143T3/da active
- 2002-05-24 AT AT02741156T patent/ATE345124T1/de not_active IP Right Cessation
- 2002-05-24 SK SK1586-2003A patent/SK15862003A3/sk unknown
-
2005
- 2005-12-20 US US11/311,406 patent/US20060148896A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2448246A1 (en) | 2002-12-05 |
| ES2275881T3 (es) | 2007-06-16 |
| PT1399143E (pt) | 2007-01-31 |
| ATE345124T1 (de) | 2006-12-15 |
| MXPA03010920A (es) | 2004-02-27 |
| JP2004532867A (ja) | 2004-10-28 |
| EP1399143B1 (en) | 2006-11-15 |
| US20060148896A1 (en) | 2006-07-06 |
| HUP0400007A2 (hu) | 2004-04-28 |
| SK15862003A3 (sk) | 2004-06-08 |
| CZ20033222A3 (cs) | 2004-06-16 |
| KR20040003031A (ko) | 2004-01-07 |
| US20040171685A1 (en) | 2004-09-02 |
| DE60216090D1 (de) | 2006-12-28 |
| PL367628A1 (en) | 2005-03-07 |
| WO2002096411A1 (en) | 2002-12-05 |
| DE60216090T2 (de) | 2007-05-31 |
| EP1399143A1 (en) | 2004-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| CY1105082T1 (el) | Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας | |
| TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| DK1425001T3 (da) | Phenethanolaminderivater til behandling af respiratoriske sygdomme | |
| BR0207640A (pt) | Composição farmacêutica oral de cefpodoxima proxetil | |
| EE200300537A (et) | Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks | |
| BR0211063A (pt) | Sais de derivados anticonvulsivantes | |
| DK1150704T3 (da) | Melagatran til behandling af betændelse | |
| EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
| SE0200198D0 (sv) | New use | |
| DK1399143T3 (da) | Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni | |
| CY1106129T1 (el) | Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος | |
| DK1399141T3 (da) | Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte | |
| SE0300535D0 (sv) | Treatment of burns | |
| IT1338456B1 (it) | Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato | |
| ITMI20041822A1 (it) | "agente terapeutico utile per il trattamento di neoplasie plasmacellulari" | |
| SE0101762D0 (sv) | New use | |
| ITRM20010319A0 (it) | Uso di una alcanoil l-carnitina per la preparazione di un medicamentoper il trattamento dell'anedonia. | |
| IT1320253B1 (it) | Composizione farmaceutica per il trattamento della malaria. |